{"id":"https://openalex.org/W1994673501","doi":"https://doi.org/10.1093/jnci/djv212","title":"Enhancing Endocrine Therapy for Hormone Receptor\u2013Positive Advanced Breast Cancer: Cotargeting Signaling Pathways","display_name":"Enhancing Endocrine Therapy for Hormone Receptor\u2013Positive Advanced Breast Cancer: Cotargeting Signaling Pathways","alternate_titles":[],"publication_year":2015,"publication_date":"2015-08-06","ids":{"openalex":"https://openalex.org/W1994673501","doi":"https://doi.org/10.1093/jnci/djv212","mag":"1994673501","pmid":"https://pubmed.ncbi.nlm.nih.gov/26251289"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/djv212","doi":"https://doi.org/10.1093/jnci/djv212","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/djv212","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1994673501"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031915637","display_name":"Stephen R.D. Johnston","orcid":"https://orcid.org/0000-0002-9072-2749","observed_orcids":["https://orcid.org/0000-0002-9072-2749","https://orcid.org/0000-0002-7641-6251"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Stephen R. D. Johnston","raw_affiliation_strings":["Department of Medicine, Royal Marsden NHS Foundation Trust, Fulham Road, Chelsea, London, UK. stephen.johnston@rmh.nhs.uk","#N#Affiliation of author: Department of Medicine, Royal Marsden NHS Foundation Trust, Fulham Road, Chelsea, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Royal Marsden NHS Foundation Trust, Fulham Road, Chelsea, London, UK. stephen.johnston@rmh.nhs.uk","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]},{"raw_affiliation_string":"#N#Affiliation of author: Department of Medicine, Royal Marsden NHS Foundation Trust, Fulham Road, Chelsea, London, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5031915637"],"corresponding_institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":null,"fwci":2.031,"has_fulltext":false,"cited_by_count":103,"citation_normalized_percentile":{"value":0.89672131,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"107","issue":"10","first_page":"djv212","last_page":"djv212"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/endocrine-therapy","display_name":"endocrine therapy","score":0.7300000190734863},{"id":"https://openalex.org/keywords/hormone-receptor-positive-breast-cancer","display_name":"hormone receptor-positive breast cancer","score":0.9430000185966492},{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.8429999947547913},{"id":"https://openalex.org/keywords/estrogen-receptor","display_name":"estrogen receptor","score":0.843999981880188},{"id":"https://openalex.org/keywords/mtor-inhibition","display_name":"mTOR inhibition","score":0.6800000071525574},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":0.9769999980926514},{"id":"https://openalex.org/keywords/exemestane","display_name":"exemestane","score":0.925000011920929},{"id":"https://openalex.org/keywords/palbociclib","display_name":"palbociclib","score":0.8669999837875366},{"id":"https://openalex.org/keywords/letrozole","display_name":"letrozole","score":0.8840000033378601},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.9440000057220459},{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":0.9440000057220459},{"id":"https://openalex.org/keywords/pi3k-akt-inhibitors","display_name":"PI3K/AKT inhibitors","score":0.7630000114440918},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.8579999804496765},{"id":"https://openalex.org/keywords/src-inhibitors","display_name":"Src kinase inhibitor","score":0.8510000109672546},{"id":"https://openalex.org/keywords/fgfr-inhibitors","display_name":"FGFR inhibitors","score":0.9959999918937683},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.9739999771118164},{"id":"https://openalex.org/keywords/molecular-profiling","display_name":"molecular profiling","score":0.5419999957084656},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.7419999837875366}],"concepts":[{"id":"https://openalex.org/C2779744173","wikidata":"https://www.wikidata.org/wiki/Q15269707","display_name":"Palbociclib","level":5,"score":0.606052041053772},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.5619434118270874},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5431763529777527},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.538844108581543},{"id":"https://openalex.org/C2775860665","wikidata":"https://www.wikidata.org/wiki/Q418819","display_name":"Exemestane","level":5,"score":0.5268650650978088},{"id":"https://openalex.org/C2778812593","wikidata":"https://www.wikidata.org/wiki/Q194974","display_name":"Letrozole","level":5,"score":0.5243759155273438},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.48470234870910645},{"id":"https://openalex.org/C46699223","wikidata":"https://www.wikidata.org/wiki/Q11078","display_name":"Endocrine system","level":3,"score":0.46131324768066406},{"id":"https://openalex.org/C2776166826","wikidata":"https://www.wikidata.org/wiki/Q415287","display_name":"Aromatase","level":4,"score":0.4525415897369385},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.44497808814048767},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.43631336092948914},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.38867855072021484},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.36217179894447327},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35358142852783203},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.35011494159698486},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3436746597290039},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3360518217086792},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.24437463283538818},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22875156998634338},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.19337651133537292},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068338","descriptor_name":"Everolimus","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000077289","descriptor_name":"Letrozole","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000730","descriptor_name":"Androstadienes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011960","descriptor_name":"Receptors, Estrogen","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D011960","descriptor_name":"Receptors, Estrogen","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D047072","descriptor_name":"Aromatase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1093/jnci/djv212","doi":"https://doi.org/10.1093/jnci/djv212","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/djv212","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:26251289","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26251289","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.856.4181","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.856.4181","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jnci.oxfordjournals.org/content/107/10/djv212.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":61,"referenced_works":["https://openalex.org/W1464936406","https://openalex.org/W1667020473","https://openalex.org/W1961026612","https://openalex.org/W1970656806","https://openalex.org/W1975570973","https://openalex.org/W1976250589","https://openalex.org/W1986757639","https://openalex.org/W1990883066","https://openalex.org/W1996965514","https://openalex.org/W1997006452","https://openalex.org/W2001585430","https://openalex.org/W2014001512","https://openalex.org/W2019711215","https://openalex.org/W2021012077","https://openalex.org/W2031131661","https://openalex.org/W2031915537","https://openalex.org/W2042976485","https://openalex.org/W2045317537","https://openalex.org/W2051748679","https://openalex.org/W2055386238","https://openalex.org/W2059567292","https://openalex.org/W2060157525","https://openalex.org/W2064823103","https://openalex.org/W2081491080","https://openalex.org/W2097698108","https://openalex.org/W2098270787","https://openalex.org/W2100506877","https://openalex.org/W2101844536","https://openalex.org/W2102148658","https://openalex.org/W2102620699","https://openalex.org/W2102685625","https://openalex.org/W2104561097","https://openalex.org/W2113458582","https://openalex.org/W2117873881","https://openalex.org/W2126783165","https://openalex.org/W2127287298","https://openalex.org/W2128605357","https://openalex.org/W2135278339","https://openalex.org/W2137511429","https://openalex.org/W2138692147","https://openalex.org/W2140055441","https://openalex.org/W2144790402","https://openalex.org/W2146280240","https://openalex.org/W2146778486","https://openalex.org/W2148345265","https://openalex.org/W2151082560","https://openalex.org/W2152289580","https://openalex.org/W2154488022","https://openalex.org/W2156391409","https://openalex.org/W2167188058","https://openalex.org/W2169988894","https://openalex.org/W2519383580","https://openalex.org/W2523546815","https://openalex.org/W2560635244","https://openalex.org/W2602595584","https://openalex.org/W2955160320","https://openalex.org/W3081400002","https://openalex.org/W4238567307","https://openalex.org/W6727143274","https://openalex.org/W6735698566","https://openalex.org/W6765047021"],"related_works":["https://openalex.org/W2019039003","https://openalex.org/W2007624356","https://openalex.org/W2198792806","https://openalex.org/W2980954961","https://openalex.org/W2029968933","https://openalex.org/W1970814316","https://openalex.org/W1973808103","https://openalex.org/W1518987711","https://openalex.org/W2378359905","https://openalex.org/W2808476554"],"abstract_inverted_index":{"Overcoming":[0],"primary":[1],"or":[2,22,75],"secondary":[3,39,83,119],"endocrine":[4,40,66,79,99,120,165,220],"resistance":[5,67,84,121],"in":[6,32,71,111,118,130,139,162],"breast":[7,225],"cancer":[8],"remains":[9],"critical":[10],"to":[11,64,76,97,152,205,218],"further":[12],"enhancing":[13],"the":[14,34,43,72,93,126,133,140,144,147,153],"benefit":[15,213],"of":[16,89,146,174],"existing":[17],"therapies":[18,166,221],"such":[19],"as":[20,60],"tamoxifen":[21],"an":[23],"aromatase":[24],"inhibitor":[25,150],"(AI).":[26],"Much":[27],"progress":[28],"has":[29,57,115],"been":[30,58,107,116],"made":[31],"understanding":[33],"molecular":[35,201],"biology":[36],"associated":[37],"with":[38,47,125,132,164,195],"resistance.":[41],"Cotargeting":[42],"estrogen":[44,223],"receptor,":[45],"together":[46,194],"various":[48],"key":[49],"intracellular":[50],"proliferation":[51],"and":[52,180,186,209],"cell":[53],"survival":[54],"signaling":[55],"pathways,":[56],"explored":[59],"a":[61],"strategy":[62],"either":[63],"treat":[65],"once":[68],"it":[69],"develops":[70],"second-line":[73],"setting":[74],"enhance":[77],"first-line":[78,141],"responsiveness":[80],"by":[81,101,122,143],"preventing":[82],"from":[85,92],"developing":[86],"via":[87],"blockade":[88],"specific":[90],"pathways":[91],"outset.":[94],"While":[95],"attempts":[96],"improve":[98],"therapy":[100,192],"adding":[102],"growth":[103],"factor":[104],"inhibitors":[105,173],"have":[106],"disappointing,":[108],"success":[109],"resulting":[110],"new":[112],"drug":[113],"approvals":[114],"seen":[117],"treating":[123],"patients":[124],"mTOR":[127],"antagonist":[128],"everolimus":[129],"combination":[131,163],"AI":[134,154],"exemestane":[135],"and,":[136],"more":[137],"recently,":[138],"setting,":[142],"addition":[145],"CDK":[148],"4/6":[149],"palbociclib":[151],"letrozole.":[155],"Numerous":[156],"other":[157],"therapeutics":[158],"are":[159,203],"being":[160],"evaluated":[161],"based":[167,189],"on":[168,190],"supportive":[169],"preclinical":[170],"evidence,":[171],"including":[172],"PI3K,":[175],"Akt,":[176],"HDAC,":[177],"Src,":[178],"IGFR-1,":[179],"FGFR.":[181],"Appropriate":[182],"clinical":[183],"trial":[184],"design":[185],"patient":[187],"selection":[188],"prior":[191],"exposure,":[193],"predictive":[196],"biomarkers":[197],"derived":[198],"through":[199],"real-time":[200],"profiling,":[202],"needed":[204],"enrich":[206],"future":[207],"trials":[208],"maximize":[210],"any":[211],"additional":[212],"that":[214],"cotargeting":[215],"may":[216],"bring":[217],"current":[219],"for":[222],"receptor-positive":[224],"cancer.":[226]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1994673501","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":22},{"year":2015,"cited_by_count":3}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
